ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.3	17.57	22.41	48.82	363.67	434.22
Short-Term Investments	60.01	110.19	160.33	217.39	-	-
Cash & Short-Term Investments	79.31	127.76	182.74	266.21	363.67	434.22
Cash Growth	-49.39%	-30.09%	-31.36%	-26.80%	-16.25%	4715.56%
Other Receivables	0.67	0.89	1	-	-	-
Receivables	0.67	0.89	1	-	-	-
Prepaid Expenses	5.27	5.68	4.49	4.76	3.35	1.77
Other Current Assets	0	0.03	0.44	-	-	-
Total Current Assets	85.26	134.35	188.66	270.97	367.02	435.99
Property, Plant & Equipment	5.13	9.63	10.84	9.81	3.47	0.05
Long-Term Investments	4.23	3.52	35.41	16.7	-	-
Other Long-Term Assets	0.7	0.27	7.64	9.01	9.69	0.01
Total Assets	95.32	147.78	242.55	306.49	380.18	436.05
Accounts Payable	4.9	4.5	8.59	8.07	3.76	0
Accrued Expenses	7.35	9.26	15.44	10.79	9.6	3.68
Current Portion of Long-Term Debt	3.04	0.44	-	-	-	-
Current Portion of Leases	2.01	1.91	-	-	0.74	-
Current Income Taxes Payable	-	-	-	-	-	0.18
Other Current Liabilities	1.55	2.39	11.97	9.46	1.19	2.35
Total Current Liabilities	18.85	18.5	36	28.33	15.3	6.2
Long-Term Debt	7	9.47	9.64	9.39	-	-
Long-Term Leases	4.14	5.16	-	-	-	-
Other Long-Term Liabilities	0.93	1.03	7.2	5.31	1.84	0.01
Total Liabilities	30.91	34.16	52.84	43.03	17.13	6.21
Common Stock	0.05	0.05	0.05	0.04	0.04	0.04
Additional Paid-In Capital	742.15	734.41	675.68	589.74	564.99	548.33
Retained Earnings	-677.83	-621.12	-486.27	-325.47	-201.99	-118.52
Comprehensive Income & Other	0.04	0.28	0.26	-0.85	-	-
Total Common Equity	64.42	113.62	189.71	263.46	363.05	429.85
Shareholders' Equity	64.42	113.62	189.71	263.46	363.05	429.85
Total Liabilities & Equity	95.32	147.78	242.55	306.49	380.18	436.05
Total Debt	16.18	16.98	9.64	9.39	0.74	-
Net Cash (Debt)	63.13	110.78	173.1	256.82	362.93	434.22
Net Cash Growth	-54.66%	-36.00%	-32.60%	-29.24%	-16.42%	11975.06%
Net Cash Per Share	1.18	2.12	4.03	6.31	9.00	23.49
Filing Date Shares Outstanding	53.55	53.38	50.15	40.86	40.63	40.13
Total Common Shares Outstanding	53.51	53.05	49.95	40.86	40.59	39.84
Working Capital	66.41	115.85	152.66	242.64	351.72	429.79
Book Value Per Share	1.20	2.14	3.80	6.45	8.94	10.79
Tangible Book Value	64.42	113.62	189.71	263.46	363.05	429.85
Tangible Book Value Per Share	1.20	2.14	3.80	6.45	8.94	10.79
Machinery	2.46	2.47	2.31	1.93	0.73	0.07
Leasehold Improvements	0.71	2.51	2.51	2.36	0.23	0.01

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q